GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verseon Corp (GREY:VERS) » Definitions » Interest Expense

Verseon (Verseon) Interest Expense : $-0.67 Mil (TTM As of Jun. 2019)


View and export this data going back to 2016. Start your Free Trial

What is Verseon Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Verseon's interest expense for the six months ended in Jun. 2019 was $ -0.50 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2019 was $-0.67 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Verseon's Operating Income for the six months ended in Jun. 2019 was $ -12.50 Mil. Verseon's Interest Expense for the six months ended in Jun. 2019 was $ -0.50 Mil. Verseon did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Verseon Interest Expense Historical Data

The historical data trend for Verseon's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verseon Interest Expense Chart

Verseon Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Interest Expense
Get a 7-Day Free Trial -0.31 -0.18 - - -0.27

Verseon Semi-Annual Data
Dec11 Dec12 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -0.09 -0.18 -0.50

Verseon Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2019 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.67 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Verseon  (GREY:VERS) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Verseon's Interest Expense for the six months ended in Jun. 2019 was $-0.50 Mil. Its Operating Income for the six months ended in Jun. 2019 was $-12.50 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2019 was $27.20 Mil.

Verseon's Interest Coverage for the quarter that ended in Jun. 2019 is calculated as

Verseon did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


Verseon (Verseon) Business Description

Traded in Other Exchanges
N/A
Address
47071 Bayside Parkway, Fremont, CA, USA, 94538
Verseon Corp is a part of the healthcare sector in the United States. It is a technology-based pharmaceutical company with a computer-driven drug discovery platform. The company designs novel drug candidates that are unlikely to be found using conventional methods. It is also engaged in drug discovery programs such as the diabetic macular edema product candidates, which treat the diseases by controlled disruption of the kallikrein kinin cascade.

Verseon (Verseon) Headlines